Intravenous desensitization to ceftazidime in cystic fibrosis patients.
Ghosal
S
S
Taylor
C J
CJ
D002442:Ceftazidime / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications* / Q000188:drug therapy; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007262:Infusions, Intravenous; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*; D012871:Skin Diseases / Q000139:chemically induced
D002442:Ceftazidime